abemaciclib,letrozole,ribociclib,palbociclib
novartis,pfizer,eli lilly
['abemaciclib', 'paloma-2', 'ribociclib', 'palbociclib']
paloma-2: no significant overall survival benefit from the addition of palbociclib to letrozole! when are we going to finally admit that palbociclib is inferior to ribociclib and abemaciclib! disappointing results to say the least!
#asco22 
Physician Scientist/Breast Oncology specialist @mdandersonnews - ????????Views are mine; Retweet ? endorsement; Scientific advisory board member @LobularBCA